Latest Cost Management News

Mesoblast has reported a strong commercial debut for Ryoncil, the first FDA-approved mesenchymal stromal cell therapy for pediatric steroid-refractory acute graft-versus-host disease, generating US$13.2 million in gross revenue in its initial quarter. The company is advancing regulatory and clinical milestones while expanding insurance coverage across the US.

AnteoTech Ltd has achieved a significant technical milestone with its 70% silicon Ultranode™ X anode, demonstrating nearly 900 cycles at 80% capacity retention, signaling a leap forward for electric vehicle battery performance and sustainability.

Hillgrove Resources reported operational gains and exploration success in Q2 2025, despite lower copper output due to grade variability. The Nugent acceleration project is progressing ahead of schedule, setting the stage for increased throughput and cost efficiencies in 2026.

Vinyl Group Ltd reports a 17% quarterly increase in cash receipts to $3.786 million, driven by acquisitions and platform growth, while targeting cash-flow breakeven by Q2 FY26 through operational efficiencies and margin improvements.

29Metals Limited reported a stronger June quarter with increased copper production at Golden Grove, offset by higher costs and deferred capital spending on the Gossan Valley project. The company also secured a final $54 million insurance payout and improved liquidity despite ongoing operational challenges at Capricorn Copper.

Alcoa Corporation reported solid Q2 2025 operational results despite tariff headwinds and lower metal prices, completing a major joint venture sale and managing a delayed smelter restart.

Brazilian Critical Minerals appoints Altris Engineering to spearhead the critical Ema Rare Earth Bankable Feasibility Study, aiming to advance its low-cost in-situ recovery project in Brazil.

Ava Risk Group reports a 5% revenue increase and a positive EBITDA turnaround in FY25, underpinned by its advanced security technologies. The company eyes over $88 million in FY26 sales opportunities despite some project delays.

Compumedics Limited has reported record sales orders and a return to profitability in FY25, setting the stage for robust growth in FY26 driven by US market traction and SaaS expansion.

City Chic Collective reports a promising FY25 with a return to profitability driven by strong ANZ sales and disciplined cost management, despite ongoing US market headwinds.

Buru Energy has taken a major step forward in developing its Rafael Gas Project through a strategic partnership with Clean Energy Fuels Australia, aiming for first cash flow by late 2027. The company also divested non-core assets to focus capital on this flagship project.

Hansen Technologies has raised its FY25 profitability outlook, driven by operational efficiencies and early powercloud profits, despite a slight revenue timing shift. The company also secured major new contracts across Europe and the US.